Trevi Therapeutics (TRVI) Debt Ratio (2020 - 2023)
Trevi Therapeutics (TRVI) posted quarterly Debt Ratio of 0.06 for Q1 2023, down 86.08% year-over-year from 0.46 in Q1 2022, and down 13.45% quarter-over-quarter from 0.07 in Q4 2022.
Trevi Therapeutics (TRVI) Debt Ratio (2020 - 2023) Analysis & Trends
Trevi Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.06 for Q1 2023.
- In Q1 2023, Debt Ratio fell 86.08% year-over-year to 0.06; the TTM figure through Mar 2023 stood at 0.06 (down 86.08% YoY), while the FY2022 annual figure was 0.07, down 80.24% from the prior year.
- Debt Ratio for Q1 2023 stood at 0.06, down from 0.07 in the prior quarter.
- The five-year high for Debt Ratio was 0.46 in Q1 2022, with the low at 0.06 in Q1 2023.
- The 4-year median for Debt Ratio is 0.3 (2020), against an average of 0.26.
- The sharpest annual moves came in 2021 and 2023: Debt Ratio jumped 83.65% in 2021, then plunged 86.08% in 2023.
- Trevi Therapeutics' Debt Ratio stood at 0.3 in 2020, then climbed by 27.16% to 0.38 in 2021, then slumped by 80.24% to 0.07 in 2022, then slipped by 13.45% to 0.06 in 2023.
- Business Quant data shows TRVI's Debt Ratio at 0.06 in Q1 2023, 0.07 in Q4 2022, and 0.08 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.08 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.46 |
| Dec 31, 2021 | 0.38 |
| Sep 30, 2021 | 0.45 |
| Jun 30, 2021 | 0.36 |
| Mar 31, 2021 | 0.33 |
| Dec 31, 2020 | 0.30 |
| Sep 30, 2020 | 0.25 |